OTL-38 Uses, Dosage, Side Effects and more
OTL-38 is under investigation in clinical trial NCT02769533 (A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma).
| Trade Name | OTL-38 |
| Generic | OTL-38 |
| Type | |
| Formula | C61H67N9O17S4 |
| Weight | Average: 1326.49 Monoisotopic: 1325.353776429 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
